JP Morgan Downgrades Karyopharm Therapeutics to Underweight

JP Morgan analyst Eric Joseph downgrades Karyopharm Therapeutics (NASDAQ:KPTI) from Overweight to Underweight.

JP Morgan analyst Eric Joseph downgrades Karyopharm Therapeutics (NASDAQ:KPTI) from Overweight to Underweight.

Total
0
Shares
Related Posts